As a form of cancer more closely correlated with diet and lifestyle factors than other cancers, colorectal cancer (CRC) is on the rise.1 Adenocarcinomas is the most common form of CRC and some of its subtypes often have very poor prognoses. Existing cancer prevention and screening best practices can help in the early identification of CRC to provide patients more options and the best opportunity to get the treatment they need.
The highly sensitive and specific Roche colorectal and gastrointestinal diagnostic tools can identify a range of these malignancies and indicate low or high levels of risk in order to more accurately personalize a patient’s treatment.
